Menu

Latest news & events

Uyên Châu Nguyên wins UM Dissertation Prize 2025

Uyên Châu Nguyên wins UM Dissertation Prize 2025

29 January 2026

During the Dies Natalis of Maastricht University, Uyên Châu Nguyên received the UM Dissertation Prize 2025.

Read more
Global research network launched to study menopause and heart health

Global research network launched to study menopause and heart health

20 January 2026

Ten international health research funders, including the Dutch Heart Foundation, are investing $10 million in a new global research network to improve early prevention of cardiovascular disease in women. The initiative focuses on understanding how menopause affects heart health and how early intervention can reduce risk.

Read more
More newsMore events
Carim Maastricht
Carim Maastricht

Hans-Peter Brunner-La Rocca

Professor

Prof. Hans-Peter Brunner-La Rocca has graduated in medicine at the University of Zurich, Switzerland. He was trained in Internal Medicine and Cardiology in Switzerland. After doing a post-doc in Melbourne, Australia, for two years, he had been working as cardiologist and heart failure specialist in Zurich. In 2002, he moved to Basel, where he was responsible for the heart failure and heart transplant services. He has obtained his lecture qualification both in Zurich and in Basel and was announced as Professor in Basel Switzerland in 2008. Since 2009, he has been working at Maastricht UMC+ as Professor of Clinical Heart Failure. He is head of the heart failure clinic and head of the division of structural heart diseases.

He has been involved in numerous research projects since many years. In particular, he has a special interest in personalised medicine in heart failure using biomarkers and has successfully led international studies related to this topic. In addition, eHealth is an important focus of research. He has published >250 research articles.

He has been working as member of different working groups of the Heart Failure Association of the European Society of Cardiology and is board member of working group on heart failure in the Netherlands.

On the one hand, he is continuing his research on biomarker in heart failure for therapy guidance. He is collaborating internationally on this topic and is participating in several large international projects in this regard. On the other hand, he is leading an international consortium, aiming to develop a personalized eHealth application to enable patients with heart failure to perform self-care, i.e. including self-prescription of medication. Recently, the consortium received 4.4 M€ to support this project from INTERREG-NWE (budget Maastricht UMC+ > 2.0 M€).

He is additionally involved in national research projects (e.g. heart-brain connection, supported by CVON) and is the local PI of several large industry sponsored RCTs. In one of them, he is the national coordinator for the Netherlands.

Hans-peter-brunner-la-rocca

Department of Cardiology
P. Debyelaan 25, 6229 HX Maastricht 
PO Box 5800, 6202 AZ Maastricht
Room number: 3.B2.031
T: +31(0)43 387 70 97

  • 2026
    • Mourmans, S. G. J., Achten, A., Weerts, J., Scheepers, M., Barandiarán Aizpurua, A., Henkens, M., Uszko-Lencer, N., Brunner-La Rocca, H.-P., Knackstedt, C., & van Empel, V. P. M. (2026). The diagnostic yield of an elaborate workup for comorbidities in a real-life heart failure with preserved ejection fraction outpatient population. European Journal of Preventive Cardiology, 33(2), 276-285. https://doi.org/10.1093/eurjpc/zwaf429
  • 2025
    • Steiner, B., Neumann, A., Schwertfeger, M., Verket, M., Romero, I., Hurtado, C., Schiefel, V., McNulty, A., Sankarpandi, S., Gingele, A. J., Helms, T. M., Brunner-La Rocca, H.-P., Zippel-Schultz, B., & iCARE4CVD Consortium (2025). Patient-reported outcome and experience measures in cardiovascular disease: a scoping review as part of iCARE4CVD. Journal of patient-reported outcomes, 9(1), Article 141. https://doi.org/10.1186/s41687-025-00980-4
    • Weerts, J., Aizpurua, A. B., Patel, R. B., van de Bovenkamp, A. A., Amin, H., Sanders-van Wijk, S., Mourmans, S. G. J., Achten, A., Handoko, M. L., Bayes-Genis, A., Brunner-La Rocca, H.-P., Shah, S. J., Knackstedt, C., & van Empel, V. P. M. (2025). A simplified approach for diagnosing heart failure with preserved ejection fraction by assessing the left atrium and natriuretic peptides. European journal of heart failure, 27(12), 2897-2902. https://doi.org/10.1002/ejhf.3651
    • Gingele, A. J., Eurlings, C., Boyne, J. J., & Brunner-La Rocca, H.-P. (2025). Identifying patients' signs and symptoms to guide eHealth-directed diuretic therapy intensification in heart failure-Insights from the trial of intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF). Wiener Klinische Wochenschrift, 137(23-24), 774-777. https://doi.org/10.1007/s00508-025-02551-5
    • Malgie, J., Wilde, M. I., Koudstaal, S., Denham, R., da Fonseca, C. A., Swart, H. P., van Ofwegen, C. E. E., Yilmaz, A., Pisters, R., Linssen, G. C. M., Faber, N., van Heerebeek, L., van de Swaluw, J. E. C., de Boer, R. A., Brunner-La Rocca, H.-P., & Brugts, J. J. (2025). Real-life implementation of guideline-recommended medical therapy in heart failure with reduced ejection fraction: Effects on prognosis and left ventricular ejection fraction. Primary results of TITRATE-HF. European journal of heart failure, 27(12), 2735-2746. https://doi.org/10.1002/ejhf.70006
    • Sikking, M., Wiethoff, I., Henkens, M., Evers, S., Stroeks, S., Venner, M., Weerts, J., Brunner-la Rocca, H.-P., Knackstedt, C., van Empel, V., Michels, M., Heymans, S., Hiligsmann, M., & Verdonschot, J. (2025). High societal costs and reduced health-related quality of life in inflammatory and systemic immune disease-associated dilated cardiomyopathies. Quality of Life Research, 34(10), 2901-2910. https://doi.org/10.1007/s11136-025-04027-5
    • Gilani, K., Verket, M., Peters, C., Dumontier, M., Rocca, H. P. B. L., & Urovi, V. (2025). CDE-Mapper: Using retrieval-augmented language models for linking clinical data elements to controlled vocabularies. Computers in Biology and Medicine, 196, Article 110745. https://doi.org/10.1016/j.compbiomed.2025.110745
    • Slob, B. P. H., Postma, M. J., Weersma, M., Rocca, H.-P. B.-L., de Jong, L. A., & Boersma, C. (2025). Cost-Effectiveness of Empagliflozin in Patients with Chronic Heart Failure Irrespective of Left-Ventricle Ejection Fraction in the Netherlands. American journal of cardiovascular drugs : drugs, devices, and other interventions, 25(5), 715-726. https://doi.org/10.1007/s40256-025-00749-6
    • Geraeds, C. B. G., Bruninx, A., Dekker, A. L. A. J., Barandiaran Aizpurua, A., Bermejo, I., & Brunner-La Rocca, H.-P. (2025). Exploring safety of down-titrating diuretics in heart failure management. European journal of heart failure, 27(8), 1393-1399. https://doi.org/10.1002/ejhf.3714
    • Weerts, J., Schroen, B. L. M., Barandiaran Aizpurua, A., Berendschot, T. T. J. M., Brandts, L., Webers, C. A. B., Simons, S. O., Meex, S. J. R., Henry, R., van der Kallen, C. J. H., Brunner-La Rocca, H.-P., Knackstedt, C., Heymans, S. R. B., de Boer, R. A., van Empel, V. P. M., & Houben, A. J. H. M. (2025). Microvascular dysfunction across organs in heart failure with preserved ejection fraction: the PROSE-HFpEF case-control study. Cardiovascular Diabetology, 24(1), Article 310. https://doi.org/10.1186/s12933-025-02850-1
Overview